| [1] |
Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer[J]. Lancet Oncol,2004,5(10):617-625.
|
| [2] |
Drell TL 4th, Joseph J, Lang K, et al. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells[J]. Breast Cancer Res Treat,2003,80(1):63-70.
|
| [3] |
Sood AK, Bhatty R, Kamat AA, et al. Stress hormone-mediated invasion of ovarian cancer cells[J]. Clin Cancer Res,2006,12(2):369-375.
|
| [4] |
Yang EV,Sood AK, Chen M, et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor,matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells[J]. Cancer Res,2006,66(21):10 357-10 364.
|
| [5] |
Lüthy IA, Bruzzone A, Piñero CP,et al. Adrenoceptors: non conventional target for breast cancer? [J]. Curr Med Chem,2009,16(15):1850-1862.
|
| [6] |
Vázquez SM, Mladovan AG, Pérez C,et al. Human breast cell lines exhibit functional alpha2-adrenoceptors[J]. Cancer Chemother Pharmacol,2006,58(1):50-61.
|
| [7] |
Vázquez SM, Pignataro O,Luthy IA. Alpha2-adrenergic effect on human breast cancer MCF-7 cells[J]. Breast Cancer Res Treat,1999,55(1):41-49.
|
| [8] |
Bruzzone A, Piñero CP, Castillo LF, et al. Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice[J]. Br J Pharmacol,2008,155(4):494-504.
|
| [9] |
Madden KS, Szpunar MJ, Brown EB. β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines[J]. Breast Cancer Res Treat,2011,130(3):747-758.
|
| [10] |
Sloan EK, Priceman SJ, Cox BF, et al. Thesympathetic nervous system induces a metastatic switch in primary breast cancer[J]. Cancer Res 2010,70(18):7042-7052.
|
| [11] |
Masur K,Niggemann B,Zanker KS,et al. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by β-blockers[J]. Cancer Res,2001,61(7):2866-2869.
|
| [12] |
Palm D, Lang K, Niggemann B, et al. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by b-blockers[J]. Int J Cancer,2006,118(11):2744-2749.
|
| [13] |
Guo K, Ma QY, Wang LC, et al. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol[J]. Oncol Rep,2009,22(4):825-830,825.
|
| [14] |
Cakir Y, Plummer HK Ⅲ,Tithof PK, et al. β-Adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines[J]. Int J Oncol,2002,21(1):153-157.
|
| [15] |
Shi M, Liu D, Duan H, et al. The β2-adrenergic receptor and HER-2 comprise a positive feedback loop in human breast cancer cells[J]. Breast Cancer Res Treat,2011,25(2):351-362.
|
| [16] |
Schiestl C, Neuhaus K, Zoller S,et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas[J]. Eur J Pediatr,2011,170(4):493-501.
|
| [17] |
Park SY, Kang JH, Jeong KJ, et al. Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism[J]. Int J Cancer,2011,128(10):2306-2316.
|
| [18] |
Pasquier E, Ciccolini J, Carre M, et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment[J]. Oncotarget,2011,2(10):797 -809.
|
| [19] |
Powe DG, Voss MJ, Habashy HO, et al. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer:an immunohistochemical study[J]. Breast Cancer Res Treat,2011,130(2):457-463.
|
| [20] |
Barron TI,Sharp L,Visvanathan K,et al. Beta-adrenergic blocking drugs in breast cancer:a perspective review[J]. Ther Adv Med Oncol,2012,4(3):113-125.
|
| [21] |
Powe DG, Voss MJ,Zänker KS, et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival[J]. Oncotarget,2010,1(7):628-638.
|
| [22] |
Barron TI,Connolly RM,Sharp L,et al. Beta blockers and breast cancer mortality:A Population-Based Study[J]. J Clin Oncol,2011,29 (19):2635-2644.
|
| [23] |
Melhem-Bertrandt A, Chavez-MacGregor M, Lei X, et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer[J]. J Clin Oncol,2011,29(19):2645-2652.
|
| [24] |
Ganz PA, Cole SW. Expanding our therapeutic options:Beta blockers for breast cancer? [J]. J Clin Oncol,2011,29(19):2612-2616.
|
| [25] |
Ganz PA, Habel LA, Weltzien EK, et al. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort[J].Breast Cancer Res Treat,2011,129 (2):549-556.
|
| [26] |
Shah SM, Carey IM, Owen CG, et al. Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study[J].Br J Clin Pharmacol,2011,72(1):157-161.
|